Article

Posterior corneal elevation values showed stability 1 year after LASIK

Evaluation of the posterior corneal elevation 1 year after LASIK showed no trend toward increased elevation that is suggestive of ectatic changes. The changes were within measurement variation and did not exceed 6 µm, according to Joseph Ciolino, MD, of Albany Medical College, Albany, NY.

Evaluation of the posterior corneal elevation 1 year after LASIK showed no trend toward increased elevation that is suggestive of ectatic changes. The changes were within measurement variation and did not exceed 6 µm, according to Joseph Ciolino, MD, of Albany Medical College, Albany, NY.

Dr. Ciolino and colleagues used Scheimpflug photographs (Pentacam, Oculus) to measure any posterior corneal elevation in 102 eyes 1 year after LASIK compared with photographs taken preoperatively.

He reported that the patients ranged in age from 22 to 56 years (average, 38 years) and the average refractive error was –4.3 D (range, –0.75 to –10 D). Average follow-up was 13.6 months, which is the average time when ectasia develops after LASIK. Average displacement was –0.47 µm, with the upper end of the range –10 µm.

"One year after LASIK, there was no significant difference in the posterior corneal elevation," Dr. Ciolino said.

The central cornea thickness, residual bed thickness, preoperative refraction, and ablation depth did not play a role in the development of ectasia, he added.

"I am not trying to suggest that post-LASIK ectasia does not exist," Dr. Ciolino said. "Contrary to previous reports that used earlier slit-scanning technology, long-term (average, 14 months) changes to the posterior corneal surface do not routinely occur in patients otherwise meeting our standard preoperative criteria."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.